ZOSANO PHARMA CORP - COM NEW (ZSAN)

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class
Equity / COM NEW
Total 13F shares
10,914,808
Share change
-3,315,245
Total reported value
$5,750,102
Price per share
$0.53
Number of holders
31
Value change
-$4,797,129
Number of buys
12
Number of sells
22

Institutional Holders of ZOSANO PHARMA CORP - COM NEW (ZSAN) as of Q4 2020

As of 31 Dec 2020, ZOSANO PHARMA CORP - COM NEW (ZSAN) was held by 31 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 10,914,808 shares. The largest 10 holders included VANGUARD GROUP INC, Aisling Capital Management LP, BlackRock Inc., ADAGE CAPITAL PARTNERS GP, L.L.C., GEODE CAPITAL MANAGEMENT, LLC, Telemetry Investments, L.L.C., Sio Capital Management, LLC, Virtu Financial LLC, Qube Research & Technologies Ltd, and NORTHERN TRUST CORP. This page lists 31 institutional shareholders reporting positions in this security for the Q4 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.